Replies to post #552650 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Amazing that it took further 6 months from June to actually publish the abstract.

Stephen Brem's comment to Dana Farber's David Reardon:

David, in addition to the external controls and the numbers, we have some unpublished data from (garbled Penn?) and Dr. Mulholland’s team has been looking at radiological markers, and we’ll present that in June. That will obviously add to the story in terms of using each patient as a control, and having another dimension of efficacy. Thank you.

[flipper44]

I’m not certain that’s the paper discussed here. For starters, Dr. Mohan does not appear to be on it.

David, in addition to the external controls and the numbers, we have some unpublished data from Penn and Dr. Mohan’s team has been looking at radiological markers, and we’ll present that in June. That will obviously add to the story in terms of using each patient as a control, and having another dimension of efficacy. Thank you. —Stephen Brem M.D., May 10, 2022